NCT01655771View on ClinicalTrials.gov

TD-1211 Single-Dose Study in Elderly and Young Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

March 31, 2013

Conditions
Constipation
Interventions
DRUG

TD-1211 Dose 1

DRUG

TD-1211 Dose 2

Trial Locations (1)

78209

ICON Development Solutions, San Antonio

Sponsors
All Listed Sponsors
lead

Theravance Biopharma

INDUSTRY

NCT01655771 - TD-1211 Single-Dose Study in Elderly and Young Healthy Subjects | Biotech Hunter | Biotech Hunter